JACOB DUNNAM: Open Payments
NPI 1508525668 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,571 in 68 payments from 15 companies in 2025. Trend: 2023 $1,019 · 2024 $1,071 · 2025 $1,571
Food & beverage: $1,571
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $280 |
| Actelion Pharmaceuticals US, Inc. | 9 | $257 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $201 |
| JAZZ PHARMACEUTICALS INC. | 6 | $199 |
| Merck Sharp & Dohme LLC | 7 | $160 |
| Viatris Specialty LLC | 5 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $85 |
| Axsome Therapeutics, Inc. | 3 | $54 |
| Amgen Inc. | 2 | $54 |
| Verona Pharma, Inc. | 2 | $43 |
Products named: XYWAV, TEZSPIRE, OPSUMIT, ZERBAXA, OFEV, DUPIXENT, BREZTRI, YUPELRI.
Industry payments across AL — which companies pay providers there.
